Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 3
2007 1
2008 1
2009 1
2010 1
2011 3
2013 3
2014 5
2015 1
2016 5
2017 2
2018 4
2019 2
2021 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.
Cohen EEW, Soulières D, Le Tourneau C, Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Zhang P, Cheng J, Swaby RF, Harrington KJ; KEYNOTE-040 investigators. Cohen EEW, et al. Lancet. 2019 Jan 12;393(10167):156-167. doi: 10.1016/S0140-6736(18)31999-8. Epub 2018 Nov 30. Lancet. 2019. PMID: 30509740 Clinical Trial.
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.
Miles D, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Campone M, Bondarenko I, Nowecki Z, Errihani H, Paluch-Shimon S, Wardley A, Merot JL, Trask P, du Toit Y, Pena-Murillo C, Revelant V, Klingbiel D, Bachelot T; PERUSE investigators. Miles D, et al. Ann Oncol. 2021 Oct;32(10):1245-1255. doi: 10.1016/j.annonc.2021.06.024. Epub 2021 Jul 2. Ann Oncol. 2021. PMID: 34224826 Free article. Clinical Trial.
Optimal differentiation of high- and low-grade glioma and metastasis: a meta-analysis of perfusion, diffusion, and spectroscopy metrics.
Usinskiene J, Ulyte A, Bjørnerud A, Venius J, Katsaros VK, Rynkeviciene R, Letautiene S, Norkus D, Suziedelis K, Rocka S, Usinskas A, Aleknavicius E. Usinskiene J, et al. Among authors: aleknavicius e. Neuroradiology. 2016 Apr;58(4):339-50. doi: 10.1007/s00234-016-1642-9. Epub 2016 Jan 15. Neuroradiology. 2016. PMID: 26767528 Review.
Rhabdoid carcinoma of the rectum.
Samalavicius NE, Stulpinas R, Gasilionis V, Baltruskeviciene E, Aleknavicius E, Mickys U. Samalavicius NE, et al. Among authors: aleknavicius e. Ann Coloproctol. 2013 Dec;29(6):252-5. doi: 10.3393/ac.2013.29.6.252. Epub 2013 Dec 31. Ann Coloproctol. 2013. PMID: 24466541 Free PMC article.
Rare types of breast carcinoma.
Gudaviciene D, Steponaviciene L, Meskauskas R, Smailyte G, Aleknavicius E. Gudaviciene D, et al. Among authors: aleknavicius e. Open Med (Wars). 2014 Nov 24;10(1):92-96. doi: 10.1515/med-2015-0016. eCollection 2015. Open Med (Wars). 2014. PMID: 28352682 Free PMC article.
Guidelines for diagnostics and treatment of aromatase inhibitor-induced bone loss in women with breast cancer: a consensus of Lithuanian medical oncologists, radiation oncologists, endocrinologists, and family medicine physicians.
Juozaitytė E, Aleknavičius E, Jančiauskienė R, Cesas A, Pipirienė-Želvienė T, Liutkauskienė S, Krasauskienė A, Vencevičienė L. Juozaitytė E, et al. Among authors: aleknavicius e. Medicina (Kaunas). 2014;50(4):197-203. doi: 10.1016/j.medici.2014.09.004. Epub 2014 Oct 1. Medicina (Kaunas). 2014. PMID: 25458955 Free article.
33 results